Biggest Losers (JLL) (VTR) (HME) (IPCC) (ARAY) on May 6

Among the big, negative movers on Friday, May 6, were Jones Lang Lasalle (JLL), Ventas (VTR), Home Properties (HME), Infinity Property (IPCC) and Accuray Incorporated (ARAY).

Jones Lang Lasalle (JLL) was down $0.94, to close at $98.69, a loss of 0.94 percent.

Ventas (VTR) fell $0.94 on the day to close at $54.54, a loss of 1.69 percent.

Home Properties (HME) dropped $0.94 to close at $61.14, a loss of 1.51 percent.

Infinity Property (IPCC) declined $0.92 to close the session at $53.47, a loss of 1.69 percent.

Accuray Incorporated (ARAY) plunged $0.92 to end the day at $7.98, a loss of 10.34 percent.

Top NASDAQ Losers (JFBI) (IGOI) (LCUT) (BASI) (ARAY) (6-10) on May 6

The top NASDAQ Losers (6-10) - as measured by percentages Friday on the Exchange - include Jefferson Bancshares, Inc. (NASDAQ:JFBI), iGo, Inc. (NASDAQ:IGOI), Lifetime Brands, Inc. (NASDAQ:LCUT), Bioanalytical Systems, Inc. (NASDAQ:BASI) and Accuray, Inc. (NASDAQ:ARAY).

Jefferson Bancshares, Inc. (JFBI) closed Friday at $3.31, down $0.55, or 14.25 percent.

iGo, Inc. (IGOI) ended the day at $2.29, down $0.38, or 14.23 percent.

Lifetime Brands, Inc. (LCUT) closed at $12.32, falling $1.62, or 11.62 percent.

Bioanalytical Systems, Inc. (BASI) closed at $2.01, declining $0.26, or 11.45 percent.

Accuray, Inc. (ARAY) closed Friday at $7.98, plunging $0.92, or 10.34 percent.

TomoTherapy (TOMO) Undervalued by Accuray (ARAY)?

Some immediate feeback from some analyzing the aquisition of TomoTherapy Inc (NASDAQ:TOMO) by Accuray Inc (NASDAQ:ARAY), is TomoTherapy is undervalued in the deal.

Accuray announced it'll acquire TomoTherapy Inc for approximately $277 million in cash and stock.

Shareholoders of TomoTherapy will receive $4.80 a share, a premium of close to 31 percent to the stock's closing price on Friday.

Terms of the deal are for $3.15 a share in cash and 0.1648 share of Accuray common stock for each TomoTherapy share.

Boards of both companies have approved the merger, and is expected to close in the second or third quarter of 2011.

Starting on July 1, 2012, Accuray said it expects the acquisition to start adding the EPS of the company.

TomoTherapy was trading at $4.57, gaining $0.89, or 24.39 percent, as of 1:38 PM EST. Accuray was at $8.99, up $1.02, or 10.14 percent.